IQV

IQV

USD

IQVIA Holdings Inc. Common Stock

$153.480-1.370 (-0.885%)

Real-time Price

Healthcare
Diagnostics & Research
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$154.850

High

$155.650

Low

$152.410

Volume

0.24M

Company Fundamentals

Market Cap

27.1B

Industry

Diagnostics & Research

Country

United States

Trading Stats

Avg Volume

1.80M

Exchange

NYQ

Currency

USD

52-Week Range

Low $135.97Current $153.480High $252.88

AI Analysis Report

Last updated: Apr 29, 2025
AI-GeneratedData Source: Yahoo Finance, Bloomberg, SEC

IQV (IQVIA Holdings Inc. Common Stock): Analyzing Recent Moves & What Might Come Next

Stock Symbol: IQV Generate Date: 2025-04-29 03:09:03

Alright, let's break down what's been happening with IQVIA Holdings based on the latest info. Think of this as getting the lowdown on the stock's recent story and what the tea leaves (and the AI) are suggesting.

Recent News Buzz: A Mixed Bag from the Pros

So, what's the word on the street from the analysts? It's a bit of a mixed picture, leaning cautious.

  • We saw HSBC downgrade the stock from a "Buy" rating all the way down to "Hold." Not only that, they slashed their price target pretty dramatically, from $260 down to $160. That's a big cut and signals less confidence from their side.
  • Barclays also pulled back a bit, moving their rating from "Overweight" to "Equal-Weight." They also lowered their price target, though not as drastically as HSBC, taking it from $235 to $170.
  • On the flip side, Truist Securities is sticking with a "Buy" rating. However, even they trimmed their price target, bringing it down from $263 to $216.

What this tells us is that while some analysts still see potential, there's a clear trend of expectations being lowered across the board recently. That kind of news can definitely weigh on a stock.

Also worth noting, the company has announced they'll be releasing their first-quarter 2025 financial results pretty soon, specifically before the market opens on May 6th. Earnings reports are always a big deal and can cause significant price swings depending on how the numbers look and what management says about the future.

Checking the Price Chart: A Rough Ride Lately

Looking at the stock's price action over the last few months, it's been a tough stretch. The price has come down quite a bit from levels seen earlier in the year, like back in January and February when it was trading closer to $200 or even higher.

There was a particularly sharp drop around early April. More recently, the stock seems to have found some footing, bouncing around in the $140 to $150 range. The last recorded price was right around $150.

So, the trend has been clearly downward for a while, but it might be trying to stabilize near its 52-week low ($135.97).

What the AI Thinks: Calling for a Short-Term Bounce

Now, let's see what the AI model is predicting for the very near future. Interestingly, the AI is quite optimistic for the next few days:

  • It's calling for a positive move today (around +1.33%).
  • It predicts further gains tomorrow (around +2.54%).
  • And another positive step the day after (around +3.42%).

This suggests the AI sees potential for a short-term upward bounce from the current price levels.

Putting It All Together & What to Watch

Okay, so we've got analysts lowering targets (a negative signal), a stock price that's been trending down but maybe stabilizing, and an AI model predicting a short-term upward move.

Based on the combination of factors, particularly the AI's bullish short-term forecast and the technical signals mentioned in the recommendation data (like positive DMI, MACD cross, and strong volume), the apparent near-term leaning seems to favor potential buyers looking for a bounce, despite the recent analyst downgrades. The stock is trading near the lower end of its recent range and its 52-week range, which some might see as a potential entry point if they believe the recent sell-off was overdone or that a short-term recovery is likely.

  • Potential Entry Consideration: If you were considering getting in, the current price area, perhaps around the last close of $150.13 or slightly lower if there's a dip, aligns with the AI's predicted starting point for an upward move and is close to the recommended entry points ($150.29, $150.84) from the broader analysis data. This level is also well above the 52-week low, suggesting some distance from the absolute bottom, but still significantly off its highs.
  • Potential Exit/Stop-Loss Consideration: For managing risk, a potential stop-loss level could be placed below recent lows or the recommended $135.25 level. This is just below the stock's 52-week low, acting as a clear line in the sand if the price continues to fall. On the upside, the recommended take-profit level is $159.79. This could be a target for a short-term trade if the AI's prediction plays out.

Remember, the big event coming up is the May 6th earnings report. That could easily override any current technical signals or short-term AI predictions. Poor results or guidance could send the stock lower, while strong performance could fuel a more significant rally.

Also, keep in mind that IQVIA is a major player in the healthcare and life sciences research space. Their business performance is tied to activity in those industries. The company also carries a notable amount of debt, which is something to be aware of from a fundamental perspective.

This analysis is based purely on the provided data points and is intended for informational purposes only. It's not financial advice. Stock markets are unpredictable, and prices can go down as well as up. Always do your own thorough research or talk to a qualified financial advisor before making any investment decisions.

Related News

Analyst Upgrades

HSBC Downgrades IQVIA Hldgs to Hold, Lowers Price Target to $160

HSBC analyst Rajesh Kumar downgrades IQVIA Hldgs from Buy to Hold and lowers the price target from $260 to $160.

View more
HSBC Downgrades IQVIA Hldgs to Hold, Lowers Price Target to $160
BusinessWire

IQVIA to Announce First-Quarter 2025 Results on May 6, 2025

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its first-quarter 2025 financial results before the market opens on Tuesday, May 6, 2025. The IQVIA management team will also host a conference call and webcast at

View more
IQVIA to Announce First-Quarter 2025 Results on May 6, 2025
Analyst Upgrades

Truist Securities Maintains Buy on IQVIA Hldgs, Lowers Price Target to $216

Truist Securities analyst Jailendra Singh maintains IQVIA Hldgs with a Buy and lowers the price target from $263 to $216.

View more
Truist Securities Maintains Buy on IQVIA Hldgs, Lowers Price Target to $216
Analyst Upgrades

Barclays Downgrades IQVIA Hldgs to Equal-Weight, Lowers Price Target to $170

Barclays analyst Luke Sergott downgrades IQVIA Hldgs from Overweight to Equal-Weight and lowers the price target from $235 to $170.

View more
Barclays Downgrades IQVIA Hldgs to Equal-Weight, Lowers Price Target to $170

AI PredictionBeta

AI Recommendation

Bullish

Updated at: May 3, 2025, 09:47 AM

BearishNeutralBullish

71.3% Confidence

Risk & Trading

Risk Level3/5
Medium Risk
Suitable For
Conservative
Trading Guide

Entry Point

$153.79

Take Profit

$156.54

Stop Loss

$138.12

Key Factors

DMI shows bearish trend (ADX:10.0, +DI:5.5, -DI:5.8), suggesting caution
Current Price is extremely close to support level ($153.41), suggesting strong buying opportunity
Trading volume is 6.7x average (21,014), indicating extremely strong buying pressure
MACD -0.0520 is above signal line -0.0545, indicating a bullish crossover

Stay Updated

Set price alerts, get AI analysis updates and real-time market news.